Effects of High-Intensity Interval Running Versus Cycling on Sclerostin, and Markers of Bone Turnover and Oxidative Stress in Young Men
Overview
Affiliations
This study compared sclerostin's response to impact versus no-impact high-intensity interval exercise in young men and examined the association between exercise-induced changes in sclerostin and markers of bone turnover and oxidative stress. Twenty healthy men (22.3 ± 2.3 years) performed two high-intensity interval exercise trials (crossover design); running on treadmill and cycling on cycle ergometer. Trials consisted of eight 1 min running or cycling intervals at ≥ 90% of maximal heart rate, separated by 1 min passive recovery intervals. Blood samples were collected at rest (pre-exercise), and 5 min, 1 h, 24 h, and 48 h following each trial. Serum levels of sclerostin, cross-linked telopeptide of type I collagen (CTXI), procollagen type I amino-terminal propeptide (PINP), thiobarbituric acid reactive substances (TBARS), and protein carbonyls (PC) were measured. There was no significant time or exercise mode effect for PINP and PC. A significant time effect was found for sclerostin, CTXI, and TBARS with no significant exercise mode effect and no significant time-by-mode interaction. Sclerostin increased from pre- to 5 min post-exercise (47%, p < 0.05) and returned to baseline within 1 h following the exercise. CTXI increased from pre- to 5 min post-exercise (28%, p < 0.05), then gradually returned to baseline by 48 h. TBARS did not increase significantly from pre- to 5 min post-exercise but significantly decreased from 5 min to 48 h post-exercise. There were no significant correlations between exercise-induced changes in sclerostin and any other marker. In young men, sclerostin's response to high-intensity interval exercise is independent of impact and is not related to changes in bone turnover and oxidative stress markers.
Civil R, Dolan E, Swinton P, Santos L, Varley I, Atherton P Sports Med Open. 2023; 9(1):85.
PMID: 37725246 PMC: 10509102. DOI: 10.1186/s40798-023-00628-x.
Salus M, Tillmann V, Remmel L, Unt E, Maestu E, Parm U Children (Basel). 2023; 10(5).
PMID: 37238398 PMC: 10216930. DOI: 10.3390/children10050850.
Staab J, Lutz L, Foulis S, Gaffney-Stomberg E, Hughes J J Appl Physiol (1985). 2022; 134(1):85-94.
PMID: 36454676 PMC: 9829485. DOI: 10.1152/japplphysiol.00442.2022.
Lavin K, Coen P, Baptista L, Bell M, Drummer D, Harper S Compr Physiol. 2022; 12(2):3193-3279.
PMID: 35578962 PMC: 9186317. DOI: 10.1002/cphy.c200033.
Prowting J, Skelly L, Kurgan N, Fraschetti E, Klentrou P, Josse A Front Nutr. 2022; 9:840973.
PMID: 35571916 PMC: 9101466. DOI: 10.3389/fnut.2022.840973.